Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/amo-pharma-announces-collaboration-with-population-health-research-institute-to-advance-proof-of-concept-clinical-trial-to-assess-efficacy-of-tideglusib-in-treatment-of-arrhythmogenic-cardiomyopathy-302062622.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-preclinical-data-showing-amo-02-improves-muscle-function-glucose-handling-and-cns-function-in-mouse-models-of-duchenne-muscular-dystrophy-301931362.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-affirming-data-from-reach-cdm-clinical-trial-for-amo-02-in-treatment-of-myotonic-dystrophy-301918241.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-completion-of-treatment-of-last-patient-in-pivotal-reach-cdm-clinical-trial-in-myotonic-dystrophy-301806216.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-mhra-confirmation-of-cdm1-rs-as-approvable-primary-outcome-measure-in-myotonic-dystrophy-301755604.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-completion-of-enrollment-in-reach-cdm-study-in-congenital-myotonic-dystrophy-301695290.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-expansion-of-pivotal-reach-cdm-study-in-congenital-myotonic-dystrophy-301449576.html
https://www.prnewswire.com/news-releases/julia-jones-joins-amo-pharma-as-chief-financial-officer-and-board-member-301399675.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-first-patient-enrolled-in-reach-cdm-x-12-month-open-label-study-301388304.html
https://www.prnewswire.com/news-releases/amo-pharma-announces-activation-of-additional-clinical-trial-sites-for-pivotal-reach-cdm-study-in-congenital-myotonic-dystrophy-301292105.html